The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
EuroIntervention 2012;8:109-116 publish online ahead of print January 2012. DOI: 10.4244/EIJV8I1A17
Gian Battista Danzi1*, MD; Bernard Chevalier2, MD; Philip Urban3, MD; Farzin Fath-Ordoubadi4, MD; Didier Carrie5, MD; Marcus Wiemer6, MD; Antonio Serra7, MD; William Wijns8, MD; Petr Kala9, MD; Amerigo Stabile10, MD; Javier Goicolea Ruigomez11, MD; Dragan Sagic12, MD; Peep Laanmets13, MD; Gerhard Strupp14, MD; Nick West15, MD; Dragica Paunovic16, MD; on behalf of NOBORI 2 Investigators
1.Ospedale Maggiore Policlinico, Milan, Italy; 2. Institut Cardiovasculaire Paris Sud, Massy/Quincy, France; 3. Hôpital de la Tour, Geneva, Switzerland; 4. Royal Infirmary, Manchester, United Kingdom; 5. Centre Hospitalier Universitaire
Aims: Previous studies for approved indications (on-label) have shown the good safety and efficacy profiles of the Nobori DES. We conducted a pr